Reneo Pharmaceuticals Inc (RPHM)
Cours de l'action
Loading...
•
Achat
•
Vente
•
Achat planifié
•
Vente planifiée
Achat net
Vente nette
Résultats financiers
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-15 | V Vente |
Cormorant Asset Management, LP Former 10% Owner |
1 813 439
-100.0%
1,853 363 023 USD |
1 813 439 -100.0% | 1,85 | 3 363 023 USD | |
| 2025-05-19 | 2025-05-15 | A Achat | Actionnaire important |
1 129 730
+inf%
1,852 090 001 USD |
1 129 730 +inf% | 1,85 | 2 090 001 USD | |
| 2025-05-19 | 2025-05-15 | A Achat | Actionnaire important |
270 270
+18.8%
1,85500 000 USD |
270 270 +18.8% | 1,85 | 500 000 USD | |
| 2025-05-14 | 2025-05-12 | V Vente |
Cormorant Asset Management, LP Actionnaire important |
24 300
-1.3%
1,9948 236 USD |
24 300 -1.3% | 1,99 | 48 236 USD | |
| 2025-04-08 | 2025-04-07 | V Vente |
President and CEO Administrateur exécutif |
516
-12.3%
2,671 378 USD |
516 -12.3% | 2,67 | 1 378 USD | |
| 2025-04-08 | 2025-04-07 | V Vente |
Chief Financial Officer Dirigeant |
1 844
-12.3%
2,674 925 USD |
1 844 -12.3% | 2,67 | 4 925 USD | |
| 2025-04-08 | 2025-04-04 | V Vente |
President and CEO Administrateur exécutif |
358
-7.9%
3,331 191 USD |
358 -7.9% | 3,33 | 1 191 USD | |
| 2025-04-08 | 2025-04-04 | V Vente |
Chief Financial Officer Dirigeant |
1 278
-7.8%
3,334 253 USD |
1 278 -7.8% | 3,33 | 4 253 USD | |
| 2024-09-26 | 2024-09-25 | A Achat | Actionnaire important |
68 746
+2.0%
1,50102 872 USD |
68 746 +2.0% | 1,50 | 102 872 USD | |
| 2024-09-26 | 2024-09-24 | A Achat | Actionnaire important |
29 600
+0.9%
1,4141 866 USD |
29 600 +0.9% | 1,41 | 41 866 USD | |
| 2024-09-19 | 2024-09-18 | A Achat | Actionnaire important |
806
+0.0%
1,401 128 USD |
806 +0.0% | 1,40 | 1 128 USD | |
| 2024-09-19 | 2024-09-17 | A Achat | Actionnaire important |
55 300
+1.7%
1,3675 108 USD |
55 300 +1.7% | 1,36 | 75 108 USD | |
| 2024-09-16 | 2024-09-16 | A Achat | Actionnaire important |
172 747
+5.5%
1,37236 871 USD |
172 747 +5.5% | 1,37 | 236 871 USD | |
| 2024-09-16 | 2024-09-13 | A Achat | Actionnaire important |
150 000
+5.0%
1,31196 950 USD |
150 000 +5.0% | 1,31 | 196 950 USD | |
| 2024-09-16 | 2024-09-12 | A Achat | Actionnaire important |
36 176
+1.2%
1,4050 523 USD |
36 176 +1.2% | 1,40 | 50 523 USD | |
| 2024-08-14 | 2024-08-14 | A Achat | Actionnaire important |
100 487
+3.5%
1,41142 008 USD |
100 487 +3.5% | 1,41 | 142 008 USD | |
| 2024-08-14 | 2024-08-13 | A Achat | Actionnaire important |
171 339
+6.4%
1,39238 590 USD |
171 339 +6.4% | 1,39 | 238 590 USD | |
| 2024-05-16 | 2024-05-14 | A Achat | Actionnaire important |
335 000
+14.3%
1,54515 900 USD |
335 000 +14.3% | 1,54 | 515 900 USD | |
| 2024-05-16 | 2024-05-14 | A Achat | Actionnaire important |
79 281
+3.5%
1,56123 678 USD |
79 281 +3.5% | 1,56 | 123 678 USD | |
| 2023-08-29 | 2023-08-28 | V Vente |
Chief Development Officer Dirigeant |
15 625
-28.3%
6,2898 058 USD |
15 625 -28.3% | 6,28 | 98 058 USD |